Written by the Dutch Psychiatric Association (NVvP) platform on 'psychedelics in psychiatry'
06.07.2025 06:53 — 👍 1 🔁 0 💬 0 📌 0
The island I live on with @renskeblom.bsky.social and the kids❤️
16.06.2025 19:23 — 👍 11 🔁 2 💬 0 📌 0
The EUDA released its European Drug Report, highlighting growing interest in psychedelics for therapeutic use. Research on psilocybin, MDMA, DMT, and LSD for PTSD and depression is advancing. New funding includes €6.5M for psychedelic therapy in palliative care. www.euda.europa.eu/publications...
07.06.2025 13:53 — 👍 1 🔁 2 💬 0 📌 0
BREAKING: Czech Republic Set to Allow Medical Use of Psilocybin
If approved by the Senate next month, it will become the third country in the world to allow access to a psychedelic ahead of conventional marketing approval.
31.05.2025 17:20 — 👍 3 🔁 3 💬 1 📌 0
I have started a 'Psychedelics Starter Pack' of Bluesky accounts related to the field.
It's very much a Work In Progress - please reply or DM with suggestions.
go.bsky.app/VNupHtA
15.11.2024 20:28 — 👍 91 🔁 15 💬 37 📌 7
YouTube video by Michel's Science Speedrun
Alpha version of my new book on ML in Genomics is online!
Super brief video intro-ing the alpha version(!!) of an free studyguide/book in sequence models and deeplearning in/for genomics.
16.05.2025 11:29 — 👍 11 🔁 4 💬 1 📌 0
Global Psychedelic Survey is the largest survey collecting data on psychedelics from across the globe. It is available in 18 (!) different languages
umich.qualtrics.com/jfe/form/SV_...
17.05.2025 11:34 — 👍 1 🔁 0 💬 0 📌 0
One of my favorite resources & collaborative opportunities for those interested in the psychedelic field!!
Amazing work!!
14.05.2025 13:20 — 👍 5 🔁 3 💬 0 📌 0
🚨 New EU Insights is out!
Catch up on PAREA & policy updates from across Europe, including:
- MAPS training in Ukraine
- ⏳ Final day to join GPS2025 bit.ly/GPS2025-survey
- New Horizon EU funding opportunities for psychedelics
📬 Read the full newsletter: tinyurl.com/insights-may25
15.05.2025 10:13 — 👍 0 🔁 1 💬 0 📌 0
Luckily, your wife packed as if we were heading for a 2 week survival camp 💕✨
21.04.2025 16:18 — 👍 1 🔁 0 💬 0 📌 0
Full bloom!
18.04.2025 16:54 — 👍 7 🔁 1 💬 0 📌 0
LSD research is starting to gain traction again. One avenue of interest is the treatment of depression. On April 7th, psychopharmacology PhD student Anna Becker presents her research on this & the effects of SSRI's and ketanserin on psychedelics. Voluntary participation fee! More at psyty.fi/becker
01.04.2025 08:19 — 👍 3 🔁 1 💬 0 📌 0
EMA has published the third revision of its guideline on depression trials, effective Sept 2025, including a dedicated section on psychedelics. PAREA contributed to the public consultation.
Read our full News Release: tinyurl.com/nr-EMA-dep-gl
31.03.2025 12:13 — 👍 1 🔁 1 💬 0 📌 1
LinkedIn
This link will take you to a page that’s not on LinkedIn
Our partners, European Psychiatric Association, published this policy paper on psychedelic treatments in psychiatry. This paper highlights specific challenges, potential benefits, & practical recommendations for clinical and research use of psychedelic treatmentsl: www.cambridge.org/core/service...
28.02.2025 16:54 — 👍 1 🔁 1 💬 0 📌 0
Become a Responsible Psychedelic Therapist | ADEPT Training Programme
Advanced Education in Psychedelic Therapy (ADEPT) is a comprehensive training programme for the next generation of skilled and ethical psychedelic therapists.
To all aspiring psychedelic assisted therapists
Deadline approaching!
OPEN Foundation has developed a 2 year international comprehensive training for training skilled, ethical, and responsible psychedelic therapists. Grounded in science. Rooted in practice. open-foundation.org/adept-psyche...
26.02.2025 05:24 — 👍 0 🔁 0 💬 0 📌 0
OPEN Foundation, member of PAREA, is launching ADEPT, a programme aiming to equip licensed mental health professionals with the skills and knowledge to become ethical and responsible psychedelic therapists. Applications are open until March 1. Read more here: tinyurl.com/open-adept
21.02.2025 13:24 — 👍 3 🔁 1 💬 0 📌 0
Thank you for sharing this case!
02.02.2025 11:09 — 👍 1 🔁 0 💬 1 📌 0
Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report
Case report of a suicide 3 days after psilocybin. Apparently there were some at least dark orange flags.
"The consistent difficulty in (...) accessing the patient’s internal l experiences may have hindered the recognition of critical psychological states."
www.sciencedirect.com/science/arti...
02.02.2025 06:57 — 👍 26 🔁 9 💬 3 📌 0
Details | Working at Bristol | University of Bristol
University of Bristol Beacon House Queens Road Bristol, BS8 1QU, UK Tel: +44 (0)117 928 9000 Contact us
🚨PLEASE SHARE: Senior reseach post: come and work at the IEU with Gib Hemani and @mendelrandom.bsky.social on Mendelian randomization, become my co-worker :) – research posts with closing date 5th February 2025.
13.01.2025 15:07 — 👍 15 🔁 21 💬 0 📌 1
Prof. Public Philosophy EUR, cinema lover, literature. Daily podcast: Zin van de Dag. Columnist for NRC
Assistant Professor Philosophy and Religion at University of Humanistic Studies
Sacred Plant Guides / Psychedelic integration workbooks for therapists / Tools for Ketamine & Psilocybin healing / Shadow Work, Spiritual Growth / Entheogen Educator and more 🍄🦋🌸♏️💗
Dedicated to spreading the transformative power of #mindfulness #meditation. Join me on a journey of self-discovery and inner peace. 🧘♀️✨
#Free, #opensource #app for #android:
https://github.com/vbresan/MindfulnessMeditation
science and culture writer and editor with words in The Guardian, NYT, Wired, The Atlantic and more
https://www.sarahsloat.net
🏴🌵
Co-Creator/Producer/Investigator - Cover Story: Power Trip w/NYMag (thecut.com/tags/cover-story-podcast/) |
Musings and such: https://linktr.ee/dnickles
Associate Prof Leiden Uni. Studying mental health problems as systems. http://eiko-fried.com. Building an early warning system for depression at http://WARN-D.com.
Psychedelic research consultant with 15 years clinical trial management and medical affairs experience.
Check out my services and connect directly at luminousrcs.com
U.S. Psychedelic Policy & Politics
Founder @ Toolbox Strategies
Fmr Campaign Manager @ Oregon Measure 109
Psychiatrist at Columbia University Medical Center. Work and interests in interventional psychiatry, ketamine, psychedelics, delirium and critical care, neuropsychiatry, medical education, and ethics. Let's connect!
We study the neurobiology of language and its relationship to consciousness, mental health, and wellbeing using neuroimaging and psychedelics at UCL 🧠 🗣️
http://www.lab-lab.org/
UCL Centre for Consciousness Research
https://www.uccr.uk/
Neuropharmacologist & bioanalyst @ University Hospital Basel. Interested in stimulants & psychedelics.
Professor of Psychiatry, Univ of Colorado School of Medicine.
Director, Psychedelic Public Policy Partnership.
Synaptic physiologist studying depression, antidepressant drug actions, and all things psychedelic in mice & people.
Link: BaleThompsonLTP.org
Associate Professor of Psychology, researcher, writer, wronger, psychedelic Indiana Jones..
IP law & strategy for psychedelics ventures & emerging tech ❀ DeSci ❀ Registered patent attorney ❀ UCSD biochem + cognitive neuroscience ❀ NYU Law ❀ SF/Oakland native ❀ www.calyx.law
Psychedelic integration, coaching, mentorship, teaching, and training.
Psychedelic Integration for the long haul.